Long-Term Persistence With the Immunomodulatory Drugs for Multiple Sclerosis: A Retrospective Database Study
Authors:
- 1 February 2012
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 34 (2) , 341-350
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Glatiramer acetate for multiple sclerosisCochrane Database of Systematic Reviews, 2010
- Persistence and adherence to disease modifying drugs among patients with multiple sclerosisCurrent Medical Research and Opinion, 2010
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Is late-onset multiple sclerosis associated with a worse outcome?Neurology, 2006
- A meta-analysis of the association between adherence to drug therapy and mortalityBMJ, 2006
- Disability progression in multiple sclerosis is slower than previously reportedNeurology, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005
- Interrupted therapyNeurology, 2003
- Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]Neurology, 2002
- Interferon in relapsing-remitting multiple sclerosisCochrane Database of Systematic Reviews, 2001